Intravesical BCG induces CD4(+) T-Cell Expansion in an Immune Competent Model of Bladder Cancer

Intravesical BCG immunotherapy is the standard of care in treating non-muscle invasive bladder cancer, yet its mechanism of action remains elusive. Both innate and adaptive immune responses have been implicated in BCG activity. Although prior research has indirectly demonstrated the importance of T...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Immunol Res
Main Authors: Kates, Max, Nirschl, Thomas, Sopko, Nikolai A., Matsui, Hotaka, Kochel, Christina M., Reis, Leonardo O., Netto, George J., Hoque, Mohammad, Hahn, Noah M., McConkey, David J., Baras, Alex S., Drake, Charles G., Bivalacqua, Trinity J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5536898/
https://ncbi.nlm.nih.gov/pubmed/28588015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-16-0267
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados